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INTRODUCTION
Helicobacter pylori infection is associated with chronic gastri-
tis, gastric and duodenal ulcers, and gastric cancer in humans
(1, 2). Eradication of H. pylori results in ulcer healing, reduc-
tion of recurrence, and complete cure of lymphomas. Several
drug treatment regimens have been developed to eradicate
H. pylori with a cure rate of up to 90% (3). Antibiotics, pro-
ton pump inhibitors, H2 blockers, and bismuth salts are the
typical modalities of treatment (4). However, these regimens
have some side effects, compliance problems, relapses, and
antibiotic resistance. Therefore, alternative anti-H. pylori or
supportive antimicrobial agents with fewer disadvantages
are necessary for the treatment of H. pylori. 
Urushiol is an oil found in plants of the Family Anacar-
diaceae and a major organic component of the sap of the lac-
quer tree (Rhus vernicifera Stokes). It causes an allergic skin
rash, inflammation, and irritation on contact, known as urush-
iol-induced contact dermatitis. Urushiol is a yellow liquid
with a boiling point of 200-210℃. It is miscible partially
in alcohol and ether, but nearly immiscible in water. Chem-
ically, urushiol is a mixture of several closely related organic
compounds. Each consists of a catechol substituted with an
alkyl chain that has 15 or 17 carbon atoms (Fig. 1). The alkyl
group may be saturated or unsaturated; urushiol oil is a mix-
ture of saturated and unsaturated molecules (5). 
Traditionally, despite an allergic reaction to urushiol and lack
of rigorous documentation, the lacquer tree was used as a folk
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In vitro Antibacterial and Morphological Effects of the Urushiol 
Component of the Sap of the Korean lacquer tree (Rhus vernicifera
Stokes) on Helicobacter pylori
Eradication regimens for Helicobacter pylori infection have some side effects, com-
pliance problems, relapses, and antibiotic resistance. Therefore, alternative anti-H.
pylori or supportive antimicrobial agents with fewer disadvantages are necessary
for the treatment of H. pylori. We investigated the pH-(5.0, 6.0, 7.0, 8.0, 9.0, and 10.0)
and concentration (0.032, 0.064, 0.128, 0.256, 0.514, and 1.024 mg/mL)-depen-
dent antibacterial activity of crude urushiol extract from the sap of the Korean lac-
quer tree (Rhus vernicifera Stokes) against 3 strains (NCTC11637, 69, and 219)
of H. pylori by the agar dilution method. In addition, the serial (before incubation, 3,
6, and 10 min after incubation) morphological effects of urushiol on H. pylori were
examined by electron microscopy. All strains survived only within pH 6.0-9.0. The
minimal inhibitory concentrations of the extract against strains ranged from 0.064
mg/mL to 0.256 mg/mL. Urushiol caused mainly separation of the membrane, vac-
uolization, and lysis of H. pylori. Interestingly, these changes were observed within
10 min following incubation with the 1×minimal inhibitory concentrations of urush-
iol. The results of this work suggest that urushiol has potential as a rapid therapeu-
tic against H. pylori infection by disrupting the bacterial cell membrane. 
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remedy for the relief of abdominal discomfort or dyspepsia
when administered mixed with boiled chicken in Korea. More-
over, some reports have demonstrated that urushiol has both
anti-microbial and anti-oxidative activities (6, 7). In this study,
we evaluated the pH- and concentration-dependent antibac-
terial activity of urushiol from the sap of the lacquer tree
against 3 strains of H. pylori. 
MATERIALS AND METHODS
Isolation of urushiol
The sap (40 mL) of lacquer tree was diluted to a volume
of 1 L by the addition of distilled water and extracted with
1 L of n-hexane twice. The hexane extract was concentrated
under reduced pressure to yield a brownish oil (26.9 g). The
oil was then purified by silica gel column chromatography
(Merck 7734) and eluted with 20% acetone/hexane. It was
further purified by the same method (Merck 9385), followed
by octadecyl silica gel column chromatography (YMC GEL
ODS-A) using a gradient of methanol in water to give urushi-
ols. The final concentration of extracted urushiol was 10 mg/
mL.
Bacterial isolates
Three strains of H. pylori (H. pylori NCTC11637, H. pylori
69 [containing plasmid pBHP69KH: kanamycin resistant
strain] and H. pylori 219 [ggt isogenic mutant: chlorampheni-
col resistant and urease-negative strain]) were obtained from
the H. pylori Korean Type Culture Collection (HpKTCC,
Department of Microbiology, Gyeongsang University Col-
lege of Medicine, Jinju, Korea). 
H. pylori was isolated from antral mucosal biopsies of pati-
ents with chronic gastritis and peptic ulcers. The H. pylori
strain was identified by colony morphology, Gram staining,
motility tests, and biochemical assays such as the urease test,
the catalase test, or the oxidase test. H. pylor was cultured in an
atmosphere 10% CO2, 5% O2, and 100% humidity at 37℃.
For transport, stab cultures were grown in Wang’s media (7.0 g
brucella broth, 1.25 g agar [Difco]and 250 mL distilled water)
and then frozen in cryomedia in the deep freezer (-70℃). For
our study, the frozen strains were processed by thawing, revi-
talizing, and lyophilizing. Every 72 hr, we subcultured H.
pylori strains on Muller-Hinton agar with aged (>2 weeks
old) 5% sheep blood and incubated in a CAMP pouch (7%
CO2) in a 37℃/5% CO2 incubator. After subculturing twice,
we checked the minimal inhibitory concentration of urushi-
ol at different pH conditions and evaluated the morphologi-
cal effects of urushiol on H. pylori.
Minimal inhibitory concentration of urushiol
The agar dilution method was used. Various concentrations
of urushiol liquid (0.032, 0.064, 0.128, 0.256, 0.514, and
1.024 mg/mL) were mixed with Mueller-Hinton agar with
aged (>2 weeks old) 5% sheep blood. A saline suspension
equivalent to a 2.0 McFarland standard (containing 1×107
to a 1×108 CFU/mL) was prepared from a 72-hr-old subcul-
ture from a blood agar plate. The inoculum (1 to 3 L per spot)
was replicated directly onto the urushiol-containing agar dilu-
tion plates. The plates were kept in a micro-aerobic atmo-
sphere produced by the CAMP pouch (7% CO2) in a 37/
5% CO2 incubator for 3 days. After 3 days incubation, we
checked the minimal inhibitory concentration. We then eval-
uated the minimal inhibitory concentration values of urush-
iol following this same procedure under different pH (5.0,
6.0, 7.0, 8.0, 9.0, and 10.0) conditions.
Ultrastructural analysis of H. pylori with electron
microscopy
For the ultra-structural analysis, H. pylori was incubated in
urushiol (0.256 mg/mL) mixed agar. Initial (before incuba-
tion) and serial fixations (3, 6, and 10 min after incubation)
were done in phosphate-buffered saline containing 2.5% glu-
taraldehyde. 
For scanning electron microscopy observations, the skin spec-
imens were fixed in 2.5% glutaraldehyde for 2 hr at 4℃, wash-
ed in 0.1 M phosphate-buffered saline (pH 7.4), postfixed in
1% osmium tetroxide in the same buffer for 90 min at 4℃,
dehydrated in a series of ethyl alcohol, exchanged through
isoamylacetate, and critical-point dried. The specimens were
coated with gold-palladium and then examined under a scan-
ning electron microscope (Tabletop microscope, TM-1000,
Hitachi high technologies, Tokyo, Japan) at 30 kV.
For transmission electron microscopy observations, the spe-
cimens were fixed in 2.5% glutaraldehyde for 2 hr at 4℃,
washed in 0.1 M phosphate-buffered saline (pH 7.4), and then
postfixed in 1% osmium tetroxide in the same buffer for 90
min. The specimens were then dehydrated through a grad-
ed series of ethanol, exchanged through propylene oxide, and
embedded in a mixture of Epon. Subsequently, ultrathin sec-
tions were obtained by an ultramicrotome (Richert-Jung,
RMC Inc., Fresno, CA, USA) with a diamond knife. Ultra-
thin sections were double stained with uranyl acetate and lead
citrate and examined under a transmission electron microscope
(JEOL-1200EX II, JEOL LTD., Tokyo, Japan) at 80 kV.
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RESULTS
Antibacterial activity of urushiol on H. pylori
The minimal inhibitory concentration (mg/mL) of the uru-
shiol against 3 H. pylori strains ranged from 0.064 to 0.256.
The minimal inhibitory concentration values of kanamycin-
resistant H. pylori (H. pylori 69) and other strains (H. pylori
NCTC11637 and H. pylori 219) were nearly equal. All strains
survived only within pH 6.0-9.0. In media of pH 5 or 10,
H. pylori did not survive after 3 days incubation, irrespective
of the concentration of urushiol (Table 1).
Morphological changes of H. pylori by urushiol
In the results of initial (before incubation) and serial fixations
(3, 6, and 10 min after incubation), separation of the mem-
brane, vacuolization, and lysis of H. pylori were the serial mor-
phological changes of H. pylori under 1×minimal inhibito-
ry concentration of urushiol. After 3 min exposure, separation
of the cell wall and vacuole and bleb formation were observ-
HP, H. pylori; MIC, Minimal inhibitory concentration.
HP
NCTC11637
HP 69 HP 219
Strains
pH 5
Survival No No No
pH 6
Survival Yes Yes Yes
MIC (mg/mL) 0.256 0.256 0.256
pH 7
Survival Yes Yes Yes
MIC (mg/mL) 0.256 0.256 0.256
pH 8
Survival Yes Yes Yes
MIC (mg/mL) 0.256 0.256 0.256
pH 9
Survival Yes/No Yes Yes
MIC (mg/mL) 0.064 0.128 0.256
pH 10
Survival No No No
Table 1. Antimicrobial activity and MIC of urushiol against 3 stra-
ins of H. pylori according to pH
Fig. 2. Serial scanning electron micrographs of H. pylori exposed to 1×minimal inhibitory concentration of urushiol. (A) Without urushiol,
most of the H. pylori bacteria are in spiral forms. (B) After 3 min exposure to urushiol, some of the H. pylori bacteria are still in the spiral
form. (C) At 6 min after exposure, most of the H. pylori bacteria have changed to a round shape and are lysed. (D) After 10 min exposure,
almost complete lysis of H. pylori bacteria is observed.
A B
C D
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ed. Leakage of some cellular material from the cytoplasmic
membrane was observed. At 6 min after exposure, significant
separation with secretory granule loss and lysis of the cyto-
plasmic membrane were observed. After 10 min exposure,
the bacteria are almost complete lysed (Figs. 2, 3).
DISCUSSION
Because antibiotic resistance is a major factor affecting the
outcome of treatment, many non-antibiotic therapies includ-
ing phytomedicines, probiotics, and antioxidants have been
investigated as potential alternatives for the treatment of H.
pylori infections (8-12). The minimal inhibitory concentra-
tions of these alternatives against H. pylori have been report-
ed as ranged from 0.075 to 12.5 mg/mL. In our study, the
minimal inhibitory concentration of the urushiol against 3
H. pylori strains ranged from 0.064 to 0.256 mg/mL. When
compared with previous reports of minimal inhibitory con-
centration of methanol, myrobalan, and plants extracts (9,
13, 14), The result of the present study suggest that urushi-
ol could be a new candidate in the treatment of H. pylori infec-
tions.
When survival of H. pylori was examined under different
pH conditions, all strains survived in pH range 6.0-9.0. Because
antibiotics have different minimal inhibitory concentrations
depending upon pH (15, 16), H. pylori eradication regimens
using antibiotics need to include proton pump inhibitors.
However, the minimal inhibitory concentration values of
urushiol revealed minimal differences under different pH con-
ditions. As a result, urushiol may not be influenced by pH
and could be a supplementary agent for an anti-H. pylori reg-
imen without proton pump inhibitor.
We evaluated the effect of urushiol on H. pylori with kana-
mycin resistance. The minimal inhibitory concentration of
urushiol in kanamycin-resistant H. pylori and other two strains
were nearly equal. In addition, the minimal inhibitory con-
centration of urushiol in H. pylori 219 (urease-negative strain)
was not different from that of urease positive H. pylori. Though
H. pylori survive in the stomach due to its urease activity (17),
Fig. 3. Serial transmission electron micrographs of H. pylori exposed to 1×minimal inhibitory concentration of urushiol. (A) In control with-
out urushiol exposure, H. pylori bacteria are in normal bacillary form. (B) After 3 min exposure, separation of the cell wall and vacuole and
bleb formation are observed (arrow). Leakage of some cellular material from the cytoplasmic membrane is observed (arrow head). (C)
At 6 min after exposure, significant separation with secretory granule loss and lysis of the cytoplasmic membrane are observed (arrow).
(D) After 10 min exposure, the bacteria are almost complete lysed (arrow).
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the presence of urease activity is not related in antibacterial
effect of urushiol on H. pylori in this study. These findings
confirm that urushiol has a different mechanism on H. pylori
eradication.
At 6 min following incubation with 1×minimal inhibito-
ry concentration of urushiol, most of the H. pylori bacteria
have changed to a round shape and are lysed. Within 10 min
after exposure, separation of the membrane, vacuolization,
and lysis of H. pylori were sequentially observed. Peroxynitrite
was reported to cause morphological changes of H. pylori with-
in 15 min (10), while some antibiotics were reported to act
on the H. pylori within 10 hr (8). Based on these reports and
the present study results, relative activity of urushiol against
H. pylori seems to be quick. The results of our work suggest
that urushiol has the potential to be used as a rapid acting
therapeutic against H. pylori infection. In addition, we could
expect that urushiol acts by disrupting the H. pylori cell mem-
brane. For the further evaluation of action mechanism, stud-
ies using gold tagging urushiol or fluorescent microscope are
warranted. 
Based on results from the present study, we would suspect
that urushiol is effective in H. pylori eradication and reduction
of H. pylori gastritis or ulcer. However, a key problem of urush-
iol compared with other new treatment modalities (18-21)
is a hypersensitive or allergic reaction. Some studies report-
ed that allergic adverse effect of urushiol could be prevented
by modification or polymerization of chemical structure (22,
23). Therefore, further preclinical or clinical studies using
chemically modified non-allergic urushiol are needed. In this
point, this in-vitro study is a basic proposal that urushiol may-
be an alternative therapeutic agent for the H. pylori eradica-
tion in the future. 
In conclusion, urushiol has the potential to act rapidly
against H. pylori infection by disrupting the H. pylori cell
membrane. 
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